Myplas USA, Inc. announced that it will issue 9,336,202 series A preferred shares at a price of $1.29 per share for gross proceeds of $12,043,700.58 on April 28, 2022. The shares will be convertible into common shares at a fixed conversion price of $1.29 per share. The round will be raised at a post-money valuation of $12,043,700.58.